Clinical Trials · NCT01760954

Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain

Name: Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Completed
Sponsor: AbbVie
Enrollment: 506
Start date: Dec 2012
Locations: See registry
Primary endpoint: Percentage of Participants With a Response for Dysmenorrhea at Month 6 Based on Daily Assessment

View Gonadorelin compound reference